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Myelination of axons by oligodendrocytes is a key feature of the remarkably fast
operating CNS. Oligodendrocytes not only tune axonal conduction speed but are also
suggested to maintain long-term axonal integrity by providing metabolic support to the
axons they ensheath. However, how myelinating oligodendrocytes impact axonal energy
homeostasis remains poorly understood and difficult to investigate. Here, we provide
a method of how to study electrically active myelinated axons expressing genetically
encoded sensors by combining electrophysiology and two-photon imaging of acutely
isolated optic nerves. We show that intravitreal adeno-associated viral (AAV) vector
delivery is an efficient tool to achieve functional sensor expression in optic nerve axons,
which is demonstrated by measuring axonal ATP dynamics following AAV-mediated
sensor expression. This novel approach allows for fast expression of any optical sensor
of interest to be studied in optic nerve axons without the need to go through the laborious
process of producing new transgenic mouse lines. Viral-mediated biosensor expression
in myelinated axons and the subsequent combination of nerve recordings and sensor
imaging outlines a powerful method to investigate oligodendroglial support functions and
to further interrogate cellular mechanisms governing axonal energy homeostasis under
physiological and pathological conditions.
Keywords: myelinated axons, intravitreal AAV injection, optic nerve recording, two-photon imaging, genetically
encoded sensors, ATP-sensor ATeam1.03YEMK
INTRODUCTION
Information processing in the brain critically relies on electrical signal transmissions along axons
interconnecting a long-range network of myriads of neurons. By insulating axons with myelin,
oligodendrocytes are essential for rapid saltatory impulse propagation (Huxley and Stämpfli, 1949)
and thereby influence the computational speed and efficiency of higher vertebrate nervous systems
(Laughlin and Sejnowski, 2003). About 50% of the human brain is composed of white matter tracts,
which mainly contain myelinated axons and their associated glial cells. Loss of axonal integrity is
detrimental for normal brain function and deficits in white matter energy metabolism, including
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perturbations in glial metabolic support to myelinated axons
(Lee et al., 2012; Saab et al., 2016), are increasingly discussed in
the pathogenesis of various neurodegenerative diseases (Nave,
2010a; Iadecola, 2013; Philips and Rothstein, 2017; Saab and
Nave, 2017).
To better understand how white matter pathology and axonal
degeneration may associate with perturbations in white matter
energy homeostasis, more insights into cellular mechanisms
regulating axonal metabolite supply and energy metabolism
are required. For example, how myelinating oligodendrocytes
regulate axonal energy metabolism andmaintain axonal integrity
under physiological or pathological conditions is still elusive
and difficult to investigate. Genetically-encoded optical sensors
enable real-time monitoring of cellular metabolite dynamics
and are becoming invaluable neurobiological tools to study
intercellular mechanisms governing brain energy homeostasis
(Hou et al., 2011; SanMartin et al., 2014b; Sotelo-Hitschfeld et al.,
2015;Mächler et al., 2016; Díaz-Garcia et al., 2017; Trevisiol et al.,
2017). The fully myelinated optic nerve is an ideal white matter
tract to examine mechanisms of axonal energy metabolism
ex vivo (Stys et al., 1991; Brown et al., 2001; Tekkök et al., 2005;
Saab et al., 2016). A recent study introduced a novel approach
to measure activity-dependent axonal ATP homeostasis in acute
optic nerve preparations by combining nerve recordings with
confocal imaging (Trevisiol et al., 2017). There, axonal sensor
expression of the FRET-based ATP sensor ATeam1.03YEMK
(Imamura et al., 2009) in optic nerves was achieved by generating
a transgenic mouse with a pan-neuronal expression of the ATP
sensor (Trevisiol et al., 2017). However, generation of new
transgenic mice is time consuming and costly if one would like to
expand the repertoire of biosensor measurements in myelinated
axons using the acute optic nerve imaging paradigm. Especially
with new and improved optical sensors being continuously
produced, we wondered whether functional sensor expression in
optic nerve axons could be achieved by viral-mediated delivery.
The aim of this study is to demonstrate that intravitreal
injection of adeno-associated viral (AAV) vectors carrying
genetically encoded sensors is suitable to drive robust and
functional sensor expression in optic nerve axons. This allows
the analysis of activity-dependent axonal metabolite dynamics in
acute optic nerve preparations by combining electrophysiology
with two-photon imaging. As a proof of principle, we tested
intravitreal injections of AAV vectors with three different
serotypes carrying the ATP sensor ATeam1.03YEMK (Imamura
et al., 2009) and evaluated axonal sensor expression and
activity in our acute optic nerve recording/imaging paradigm.
Intravitreal AAV-mediated sensor expression and subsequent
two-photon imaging of myelinated axons represents a powerful
approach to gain more insights into cellular and molecular
mechanisms governing white matter energy metabolism.
MATERIALS AND METHODS
Animals
All animal experiments were approved by the local veterinary
authorities in Zurich and were according to the guidelines of
Swiss Animal Protection Law, Veterinary Office, Canton Zurich
(Animal Welfare Act of 16 December 2005 and Animal Welfare
Ordinance of 23 April 2008). Mice had free access to food and
water and were kept with an inverted 12 h light/dark cycle.
Intravitreal AAV vector injections were performed in 8–10 weeks
old wild type mice (C57BL/6J; Charles River) and optic nerve
imaging experiments were performed starting from 3 weeks
to 4 weeks after the intravitreal injection. Transgenic mice
B6-Tg(Thy1.2-ATeam1.03YEMK)AJhi (Trevisiol et al., 2017) at
the age of 12–15 weeks were also used for imaging experiments.
Safety measures for handling AAV viral vectors were according
to the institutional biosafety procedures of the University of
Zurich.
Experimental Design
Studying energymetabolism in white matter tracts is challenging,
but essential to understand how axonal compartments, which
are shielded by myelin sheaths, take up metabolites, regulate
their energy resources and maintain functional integrity (Nave,
2010b; Saab et al., 2013; Trevisiol et al., 2017). We describe a
novel approach which allows any genetically encoded optical
sensor of interest to be rapidly expressed and studied in
optic nerve axons of adult mice (Figure 1). Since all optic
nerve axons descend from retinal ganglion cells (RGCs) located
in the retina, intravitreal injection of AAV vectors enables
sensor expression in RGCs and their myelinated axons. Around
3–4 weeks after intravitreal AAV injections, robust sensor
expression in optic nerve axons was achieved and nerves
were prepared for ex vivo recordings and axonal imaging.
Electrical nerve stimulations and recordings of compound
action potentials (CAPs) were combined with two-photon
imaging. We demonstrate the usefulness of this protocol by
monitoring axonal ATP level changes following intravitreal
AAV-mediated delivery and expression of a FRET-based ATP
sensor ATeam1.03YEMK (Imamura et al., 2009). For comparison,
we also monitored axonal ATP dynamics in optic nerves from
transgenic mice constitutively expressing the same ATP sensor
in neuronal/axonal compartments (Trevisiol et al., 2017).
Intravitreal AAV Injections
Mice were anesthetized with an intraperitoneal injection of
fentanyl (0.05 mg/kg; Fentanyl Sintetica, Sintetica), midazolam
(5 mg/kg; Dormicum, Roche), and medetomidine (0.5 mg/kg;
Domitor, Orion Pharma) mixed in NaCl (0.9%; Fleischmann
et al., 2016). For pupil dilation, first cyclopentolate (1%;
Cyclogyl, Alcon) and then phenylephrine (5%; Neosynephrin-
POS, URSAPHARM) were each applied topically to the
eyes for 1–2 min. Prolonged light exposure to the mouse
was avoided whenever possible once pupils were dilated.
Eyes were kept moisturized with the transparent Viscotears
liquid gel (Alcon) and mouse body temperature was kept
stable at 37◦C throughout the intravitreal AAV injection
procedure (Figure 2). Under microscopic control (SteREO
Discovery.V20, Zeiss) an incision was made into the sclera
(1–2 mm posterior of the superior limbus) using a sterile,
sharp 30-gauge (G) needle (insulin syringe, Omnican 50, Braun;
Figure 2A). Great care was taken not to damage the lens or
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FIGURE 1 | Experimental paradigm: intravitreal adeno-associated viral (AAV) vector injection and subsequent two-photon imaging of genetically encoded biosensors
in optic nerve axons. (A) Injection of AAV vector carrying genetically encoded sensor into the vitreous humor of the mouse eye at the age of 8–10 weeks. Robust
sensor expression in optic nerve axons for imaging experiments is achieved starting from 3 weeks to 4 weeks after the injection. (B) Acute optic nerve preparation for
combined electrophysiology and two-photon imaging of myelinated axons. Simultaneous monitoring of stimulus-evoked compound action potentials (CAPs) and
biosensor activity enables studying activity-dependent axonal metabolite dynamics.
FIGURE 2 | Intravitreal AAV injection procedure. (A) Depiction of the mouse
eye (frontal view) with a dilated pupil held by the scleral connective tissue with
forceps. Using a sharp 30G needle (e.g., insulin syringe) an incision is made
into the sclera. (B) A Hamilton syringe with a 34G blunt needle is carefully
inserted into the incision and the AAV viral suspension is slowly injected into
the vitreous. By adding fluorescein dye (green) to the viral suspension, the
intravitreal injection can be observed by the homogenous diffusion of the
green dye inside the vitreous.
retina. After removing the 30G needle, a 34G blunt needle
(12.70mm/pst3, BGB, HA-207434) attached to a microliter
Hamilton syringe (10 µl Syringe Model 701) was carefully
inserted into the same incision (Figure 2B) and 1–1.5 µl
of viral suspension was slowly injected (0.05–0.1 µl/s) into
the vitreous. For a better monitoring of the AAV injection
into the vitreous, we mixed 1 µl of fluorescein (0.1 mg/ml
in PBS) in 10 µl of undiluted viral suspension (see below).
Successful injections were observed by the homogenous diffusion
of the green fluorescein dye inside the vitreous (Figure 2B).
The needle was kept inside the vitreous for 1–2 min after
the injection to prevent reflux of viral suspension, before
carefully removing the needle. Both eyes were injected. After
intravitreal AAV injections, antibiotic eye drops (Ofloxacin
0.3%, Floxal UD, Bausch + Lomb) were applied and mice
were injected subcutaneously with the analgesic buprenorphine
(0.1mg/kg, Temgesic, Indivior Schweiz AG). By antagonizing the
anesthesia with intraperitoneal administration of the antagonists
(a mixture of atipamezole (2.5 mg/kg; Revertor, Virbac) and
flumazenil (0.5 mg/kg; Anexate, Roche)) mice typically regained
consciousness within 5 min when placed back in the home cage
for recovery.
AAV Viral Vectors
The production, purification and quantification of single-
stranded (ss) AAV vectors were performed by the viral vector
facility (VVF) of the Neuroscience Center Zurich (ZNZ) as
described (Zolotukhin et al., 1999; Paterna et al., 2004). The
AAV viral vectors used in this study express the ATP sensor
ATeam1.03YEMK (Imamura et al., 2009) under the control of
the human synapsin promoter (hSyn1-ATeam1.03YEMK-WPRE-
hGHp(A)) and three different AAV vector serotypes, ssAAV-
2/2, -DJ/2 and -9/2 (Samulski et al., 1989; Gao et al., 2004;
Grimm et al., 2008), were generated and tested. Intravitreal
AAV injections were performed with undiluted viral suspensions
and the physical titers of ssAAV-2/2, -DJ/2 and -9/2 were
6.2 × 1012 vg/ml (vector genomes/milliliter), 5.4 × 1012 vg/ml
and 8.1 × 1012 vg/ml, respectively. The VVF repository
identifier of the hSyn1-ATeam1.03YEMK AAV vectors is v244 and
all AAV serotypes as well as detailed information on AAV
production, including vector maps, can be obtained from the
VVF homepage1 .
1https://www.uzh.ch/vvf/ordersystem/
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Optic Nerve Preparation Procedure
Optic nerves were prepared for imaging experiments 3–6 weeks
after intravitreal AAV vector injections. Mice were deeply
anesthetized with isoflurane before decapitation. The skin
covering the skull was cut longitudinally with a surgical blade
(Figure 3A) and the two skin flaps were held with the index
and thumb fingers. After removing the surface connective tissue
above the eyes (Figure 3B), optic nerves were separated from
the eyeballs by carefully cutting with surgical scissors (Fine Iris
Scissors, FST, 14106-09) into the eye socket behind the eyeballs
(Figure 3C). Care was taken not to damage the eyeballs. The
exit tips of the nerve heads were visible as white dots at the
back of each eyeball after the separation (Figure 3D). Next, the
skull was cut with surgical scissors and carefully removed to
expose the brain (Figure 3E). Then the brain was pulled back
to slowly extract the nerves out of the optic canals (Figure 3F).
Importantly, the nerves should slip out easily without any
stretching. Once pulled out, the nerves were flushedwith artificial
cerebrospinal fluid (ACSF) to straighten them on the ventral
surface of the brain (Figure 3G). Using spring scissors (Cohan-
Vannas Spring Scissors, FST, 15000-02) the chiasm was cut as
depicted in Figure 3G, leaving the nerves still attached to half of
the chiasm by which then the nerve pair was lifted (Figure 3H)
and transferred to the recording chamber.
Recording Setup Preparation
Optic nerve recordings and imaging were performed in an
interface recording chamber (Harvard apparatus, Base unit
(BSC-BU, 65-0073) and Haas top (BSC-HT, 65-0075)) with
custom-mademodifications to theHaas top unit: the inside edges
of the chamber were milled down in a ∼45◦ angle to ∼2 mm
which created adequate space for positioning both suction
electrodes and the objective (see Figures 4A,F). The recording
chamber was continuously perfused with ACSF (containing in
mM: NaCl, 126; KCl, 3; CaCl2, 2; NaH2PO4, 1.25; NaHCO3,
26; MgSO4, 2; D-glucose, 10; pH 7.4) which was constantly
bubbled with 95% O2 and 5% CO2, and gravity-fed into the
recording chamber at a flow rate of ∼6 ml/min. Temperature
was maintained at 37◦C using a temperature controller (npi
electronics, TC-10) with the sensor (TS-100, npi) attached inside
the chamber. To reduce bubble formations inside the recording
chamber, which could become an issue during imaging, the
ACSF glass bottle was additionally preheated (during bubbling)
in a plexiglass-walled (for better visibility) water bath (Julabo)
at 37◦C. The custom-made suction electrodes (Stys et al., 1991;
Figures 4A–F) were back-filled with ACSF and positioned
in the chamber using micro-manipulators (Mini 25, Luigs &
Neumann).
The excised optic nerve pair was placed on filter paper
(Macherey-Nagel, MN 615) strips inside the chamber as depicted
in Figure 4C. Before starting the experiment, filter paper strips
were prepared by cutting two strips of ∼2 mm width, two strips
of ∼1.5 mm width and two trapezoid-shaped filter paper stacks
(four layers) and arranged in the recording chamber as shown
in Figure 4B. Filter papers were rinsed thoroughly with ACSF
to remove any dust particles and the chamber was freed from
bubbles before nerve preparation. After the excised nerve pair
was placed on the central 2 mm filter paper strips (two layers)
with the chiasm facing the recording electrode, one nerve was
carefully cut from the chiasm using spring scissors (Figure 4C).
The second nerve still attached to the chiasm was gently moved
to the side and served only as a backup in case the first nerve
was damaged during preparation (absence of CAP response) or
lacked sensor expression due to a failed intravitreal injection.
The nerve on the filter papers was positioned between the
electrodes and each nerve end was inserted into the suction
electrodes by slowly pulling back the plunger of the ACSF-filled
syringes (attached to the electrodes via tubing; Figure 4D). The
nerve ends should fit tightly into the electrodes and were not
inserted more than 0.5 mm. The two trapezoid-shaped filter
paper stacks (four layers) were carefully placed on the 2 mm
filter paper strips above and below the nerve, leaving a ∼1 mm
FIGURE 3 | Procedure of optic nerve removal. (A) Following anesthesia and decapitation the skin covering the skull is cut longitudinally. (B,C) The optic nerves are
separated from the eyeballs after removing connective tissue by carefully cutting into the eye socket behind the eyeballs. (D) After the separation the exit tips of the
nerve (red circle) are visible as white dots at the back of the eyeballs. (E) The skull is removed to gain access to the brain. (F) The brain is pulled backwards to extract
the optic nerves (red arrows F–H) from the optical canals. Nerves should come out easily still attached to the chiasm. (G) With drops of artificial cerebrospinal fluid
(ACSF), nerves are flushed to straighten them, and the chiasm is cut (dashed lines) leaving half of the chiasm still connected to the nerve pair. (H) Optic nerves are
carefully lifted by holding at the chiasm (red asterisk) and then transferred to the recording chamber.
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FIGURE 4 | Optic nerve preparation in setup for electrophysiology and
imaging. (A) Photograph of the recording chamber with stimulation (Stim.) and
recording (Rec.) electrode. Orange arrow heads highlight the modification to
the Haas top unit of the chamber; i.e., the inside edges (dotted lines) are
milled down in a 45◦ angle to create better access for electrodes and
objective, see also (F). Blue circles and arrow indicate location of ACSF inflow
into the chamber and direction of flow, respectively. Black rectangle outlines
the region magnified in (B) showing the arrangement of filter papers around
the electrodes. (C) The optic nerves (red arrow) are placed on the central filter
paper strips (two layers) with the chiasm facing the recording electrode. One
nerve is carefully cut from the chiasm (dashed red line) and moved towards
the electrodes. (D) Depicted is how the nerve is positioned on the filter paper
strips between the electrodes with each nerve end inserted into the suction
electrodes (red circles). The other nerve is placed on the side as backup (red
asterisk). (E) Organization of the remaining filter papers above and below the
electrodes before (F) placing the objective above the nerve (red arrow) by
dipping into the created ACSF pool. Orange arrows heads indicate the
modification (milling) of the inside edges of the chamber (dotted lines).
gap above and below the electrodes (Figure 4E). Then the two
1.5 mm filter paper strips (single layers) were placed across the
electrodes as shown in Figure 4E. This arrangement created a
steady ACSF pool around the nerve and stabilized the optic nerve
for subsequent imaging. Then the objective (working distance
2 mm) was positioned above the nerve by dipping it into the
ACSF pool (Figure 4F). The imaging plane of the objective was
focused on the nerve surface by visual control using a wide-field
camera (installed in a separate optical path of the microscope).
Finally, the syringes connected to the suction electrodes were
carefully detached to release the pressure on the nerve ends which
minimizes drift while imaging later. The nerve was allowed to
equilibrate in this arrangement with the microscope objective
in place and continuous ACSF flow for at least 30 min before
starting the experiments.
Optic Nerve Electrophysiology and
Two-Photon Imaging
Nerve Stimulation and CAP Recording
Throughout all initial adjustments and during the equilibration
phase (see above), the optic nerve was stimulated every 10 s
and the evoked CAP response (Figure 5A) was monitored.
Stimulations (square-wave current pulses of 50 µs and
0.8 mA) were triggered using a stimulus generator (STG 4002-
1.6 mA, Multichannel Systems) which was connected to the
stimulation electrode and controlled by the computer software
MC_Stimulus. The recording electrode was connected to a
miniature pre-amplifier (2× gain MPA, Multichannel Systems)
and a data acquisition system (USB-ME16-FAI, Multichannel
Systems). The signal was amplified 200 times, filtered at 30 kHz,
and acquired at 50 kHz using the acquisition software MC_Rack
(Multichannel Systems; RRID:SCR_014955). Stimulating the
nerve with 0.8 mA elicited a maximal CAP response, meaning
that all optic nerve axons are likely to have been excited (Stys
et al., 1991). During the equilibration phase (especially after
releasing the suction pressure from the nerve) the CAP amplitude
typically dropped by 10%–20% while the nerve was adjusting
to the electrodes. However, the CAP response normally became
stable within 15–20 min.
FIGURE 5 | Analysis of optic nerve CAP recordings. (A) Example traces of the
three-peak shaped CAP responses at 0.4 Hz baseline (BL) and at 1, 10,
25 and 50 Hz nerve stimulations. CAP traces of 1–50 Hz are taken from the
end of a 1 min stimulus train. (B,C) Average time course of relative changes in
peak 2 amplitude (B) and peak 2 latency (C) during the stepwise increase in
stimulation frequency. Changes (in %) are presented relative to the 0.4 Hz BL
recordings. Note that with higher stimulation frequencies, CAP peak amplitude
decreases and peak latency increases. (D) Relative changes (in %) in partial
CAP (pCAP) area with increasing stimulation frequency. The pCAP area is
defined as the area under the curve (AUC) of the first two CAP peaks
(indicated by the gray area in (A)) integrating changes in amplitude and
latency. (E) Gradual decline of the CAP response (shown in 15 s intervals) to
full conduction block (red trace) during inhibition of mitochondrial respiration
with NaN3 (5 mM). (F) Average time course of the relative CAP area decay and
recovery when challenged with NaN3 (5 mM) for 6 min. CAP area is
normalized to BL before pharmacological treatment. In (B–D,F) data is
represented as means ± SEM, n = 5 nerves from five animals.
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Axonal Sensor Imaging
Optic nerve axons expressing the FRET-based ATP sensor
(FRET pair: mseCFP and cp173-mVenus; Imamura et al., 2009)
were imaged with a custom-built two-photon laser scanning
microscope (Mayrhofer et al., 2015) using a Ti:Sapphire laser
(Chameleon Ultra II; Coherent) at 870 nm wavelength and
equipped with a 25× water immersion objective (XLPLN
25×/1.05 WMP2, Olympus). Fluorescence emission was
detected with two GaAsP photomultiplier modules (Hamamatsu
Photonics, H10770PA-40 SEL) using a dichroic beam-splitter
(506 nm edge, BrightLine; Semrock, FF506-Di03-25 × 36) and
two band-pass filters 545/55 nm (yellow channel) and 475/50 nm
(blue channel; BrightLine; Semrock, FF01-545/55-25, FF02-
475/50-25). Image acquisition was controlled by the MATLAB
(RRID:SCR_001622) software ScanImage (RRID:SCR_014307;
Pologruto et al., 2003). Laser power was adjusted between
5 and 15 mW for axonal sensor imaging. Initial overview stacks
of axonal sensor expression were acquired at a resolution of
512 × 512 pixels. For sensor imaging during nerve stimulations,
frames were acquired 15 to 20 µm below nerve surface with
8–10× digital zoom at 256 × 256 pixels and a pixel dwell
time of 6.4 µs and images of both channels were collected
simultaneously with two detectors every 2 s. CAP recordings
and metabolite sensor imaging were synchronized using a
TTL trigger driven by the stimulus generator to initiate both
acquisitions (electrophysiology and imaging) as well as the
stimulation protocol.
Stimulation Protocol and Pharmacology
We measured relative ATP level changes upon axonal
stimulations using the following protocol: The optic nerve
was first stimulated at 0.4 Hz for 1 min to acquire baseline (BL)
values and was followed by a stepwise increase in stimulation
frequency to 1, 10, 25 and 50 Hz, with each stimulus train lasting
1 min. A recovery period of 4 min with 0.4 Hz stimulations was
added at the end of the stimulus sequence. During BL/recovery
periods CAP responses were acquired every 2.5 s whereas during
the high frequency trains CAPs were collected every second.
Sensor images were acquired every 2 s throughout the entire
9 min stimulation protocol. This sampling rate is in line with
the expected kinetics of the relative ATP level changes (Trevisiol
et al., 2017) and avoids unnecessary bleaching. In a separate set
of experiments, we pharmacologically blocked mitochondrial
respiration using 5 mM NaN3 (Sigma-Aldrich, S2002). The drug
was prepared in a separate ACSF bottle, bath applied to the nerve
for 6 min and followed by a washout period for about 15 min.
Before, during and after drug application sensor images and
CAPs were acquired every 2 and 2.5 s, respectively.
The nerve could be studied for several hours with different
brief stimulation protocols without any major changes in
conduction performance. However, care should be taken
if stimulation protocols (e.g., prolonged high frequency
stimulations above 50 Hz) or pharmacological challenges (e.g.,
chemical ischemia) are applied that critically compromise
axonal conduction and integrity. After such interventions the
experiment should be concluded if reliable and reproducible
measurements are desired.
Analysis of CAP Recordings and Sensor Imaging
The stimulus-evoked CAP response typically has three peaks,
most likely representing subgroups of axons with different
conduction speeds, and the overall area under the curve
(AUC) of the CAP response is proportional to the total
number of excited axons (Stys et al., 1991; Baltan et al., 2008;
Saab et al., 2016). During high-frequency stimulations, CAP
peak amplitudes generally decreased whereas peak latencies
increased (Figure 5A). These changes were best assessed for
the second and most prominent CAP peak (Figures 5B,C).
Additionally, we measured relative changes in the partial CAP
(pCAP) area (Figure 5D), i.e., the AUC of the first and
second CAP peaks, typically in a range of 1 ms from the
beginning of the CAP response as indicated in Figure 5A.
The pCAP area integrates changes in amplitude and latency
of the first two CAP peaks (Figure 5C), which likely derive
from large and medium-sized axons that are reliably detected
with conventional laser scanning microscopy (axonal diameters
larger than ∼0.5 µm). Relative changes in CAP amplitude,
latency and AUC were calculated by normalizing values to
BL prior to high-frequency simulations or NaN3 application.
The normalized time course traces from nerve recordings were
pooled, and data is presented as means ± SEM. CAP recordings
were analyzed using a custom-writtenMATLAB script, which we
provide for download from https://github.com/EIN-lab/CAP-
analysis. However, the MATLAB script would need minor
adjustments if other acquisition software formats than MC_Rack
(multichannel systems; RRID:SCR_014955) are used.
An imaging time-series of the acquired mseCFP and mVenus
channels was collected during each imaging experiment. The
average signal intensity (of all axons per field of view) of
each channel was extracted using ImageJ (RRID:SCR_003070;
Schneider et al., 2012). For every acquisition timepoint the
ratio of mVenus/mseCFP was calculated, and the time course
of the ratios was normalized to the corresponding BL. The
normalized time courses were pooled per animal and presented
as means± SEM. For comparisons of relative ATP level changes
during high-frequency stimulations or mitochondrial block with
NaN3, the slopes of the normalized time courses were calculated
by linear fitting using GraphPad Prism (RRID:SCR_002798) and
presented in summary plots as means± SD. The ATP decay and
recovery rates of the NaN3 experiments were determined from
linear fits between 25% and 75% of the normalized decay and
recovery curves. For all experiments only one nerve per animal
was used and n represents number of animals.
RESULTS
Using intravitreal delivery and virus-mediated expression of
genetically encoded sensors in optic nerve axons, we provide
a novel method to measure axonal metabolite dynamics by
combining optic nerve electrophysiology with two-photon
imaging (Figures 5, 6). We showcase this approach by
imaging axonal ATP dynamics following intravitreal AAV vector
injections and expression of the ATP sensor ATeam1.03YEMK
(Imamura et al., 2009; Figure 6). Three different AAV vector
serotypes (AAV2, AAVDJ and AAV9) were tested and axonal
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FIGURE 6 | Axonal ATP sensor imaging following intravitreal AVV vector injections. (A) Example two-photon scan images of axons expressing the ATP sensor
(ATeam1.03YEMK) in acute optic nerve preparations from a transgenic mouse [B6-Tg(Thy1.2-ATeam1.03YEMK)AJhi] and from mice with intravitreal injection of AAV
vectors [hSyn1-ATeam1.03YEMK-WPRE-hGHp (A)]. Efficacy of sensor expression (number of axons) differs between the AAV vector serotypes tested, with AAV2 and
AAVDJ revealing abundant expression whereas with AAV9 only very sparse axonal expression is detected. Both channels, mseCFP (blue) and cp173-mVenus
(yellow), of the FRET sensor are depicted. Scale bars 10 µm. (B–D) Average time course of relative changes in axonal ATP levels upon stepwise increase in
stimulation frequency in nerves from transgenic mice (n = 7; B) and from nerves following intravitreal AAV injections of serotypes AAV2 (n = 5; C) and AAVDJ (n = 4;
D). Changes (in % ± SEM) are presented relative to the 0.4 Hz BL. (E–G) Relative ATP level changes in axons during and after mitochondrial respiration block, by
5 mM NaN3 bath application for 6 min, in nerve preparations from transgenic mice (E), AAV2 (F) and AAVDJ (G) injected mice. To evaluate kinetics of ATP level
changes (i.e., decay and recovery rates) the time course of the Venus/CFP ratios is normalized to BL (before NaN3 application; set as 1) and to the plateau level
reached with NaN3 (set as 0). Depicted are averaged time courses from 4 to 7 nerves ± SEM. (H) Axonal ATP levels drop faster (i.e., increase in ATP consumption)
with higher stimulation frequencies (B–D) and is exemplified here by calculating the ratios of the ATP level decline slopes (red dashed lines in B–D) upon 50 and
25 Hz stimulations. A two-fold increase in stimulation frequency reveals on average a 2.7 ± 0.4 (Tg), 2.4 ± 0.4 (AAV2) and 2.7 ± 0.4 (AAVDJ) fold increase in ATP
level drop. No overt differences between groups, n = 4–7 ± SD, Welch’s t-test. (I,J) Summary plots of axonal ATP level decay (I) and recovery (J) rates from NaN3
experiments (in E–G). Rates (per s) were determined by linear regression between 25% and 75% of the normalized decay and recovery curves (red dashed lines in
E–G; R2 of linear fits ≥0.98). Average decay rates (I) are −0.006 ± 0.0003 (Tg), −0.008 ± 0.001 (AAV2) and −0.008 ± 0.001 (AAVDJ) and average recovery rates
(J) are 0.013 ± 0.0003 (Tg), 0.012 ± 0.001 (AAV2) and 0.012 ± 0.001 (AAVDJ). No overt differences between groups, n = 4–7 ± SD, Welch’s t-test.
ATP sensor expression (driven by the hSyn1 promoter)
was assessed. We observed that transduction efficacy varied
strongly between the serotypes used, which was easily judged
by the overall abundance of axons expressing the ATP
sensor during acute optic nerve imaging (Figure 6A, right
panels). Three to six weeks after intravitreal injections,
AAV2 and AAVDJ revealed ample axonal expression whereas
with AAV9 vectors only very sparse axonal expression was
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achieved. For comparison, optic nerves from transgenic mice,
with a developmental, pan-neuronal expression of the same ATP
sensor, show very abundant axonal expression levels (Trevisiol
et al., 2017; Figure 6A, left panel).
To test axonal ATP sensor performance, optic nerves
were metabolically challenged with increasing stimulation
frequencies (Figures 6B–D) and by pharmacologically blocking
mitochondrial ATP production (Figures 6E–G). Here, we only
focused on nerves from AAV2 and AAVDJ injected mice
as they revealed reliable and reproducible axonal expression
compared to AAV9. As expected, a stepwise elevation in
stimulation frequencies from a 0.4 Hz BL acquisition to 1, 10,
25 and 50 Hz revealed a faster axonal ATP level decline with
increasing stimulation frequencies. A steeper axonal ATP level
drop likely indicates higher ATP consumption rates due to
increasing frequency-dependent energy demands. For example,
a two-fold increase in stimulation frequency from 25 Hz to
50 Hz caused on average a 2.6-fold increase in axonal ATP
level depletion (Figure 6H). Similarly, CAP performance also
declines with increasing stimulation frequencies which is best
described by the drop in CAP amplitude and pCAP area
(Figures 5B,D). Moreover, when mitochondrial respiration and
thereby ATP production was transiently blocked using 5 mM
NaN3 (bath applied for 6min) axonal ATP levels rapidly declined
(Figures 6E–G) leading to a complete nerve conduction block
(Figures 5E,F). This was reversed by washout of NaN3 which
quickly replenished axonal ATP back to BL levels and completely
restored axonal firing. We did not observe overt differences in
ATP sensor dynamics between AAV-mediated sensor expressing
nerves and transgenic nerves when comparing overall ATP decay
and recovery kinetics (Figures 6I,J), which are also similar
to previous results (Trevisiol et al., 2017). Hence, intravitreal
injection of AAV vectors carrying genetically encoded sensors is
a fast and reliable approach to drive functional sensor expression
in optic nerve axons and by combining electrophysiology
with two-photon imaging axonal metabolite dynamics can be
studied.
DISCUSSION
Intravitreal delivery of AAV vectors to induce protein expression
in RGCs is a widely used and safe technique causing no
harm to retinal cells or alterations in retinal physiology
(Martin et al., 2002; Hellström et al., 2009; Schön et al., 2015;
Smith and Chauhan, 2018). We exploited this technique to
drive metabolite sensor expression in optic nerve axons and
to study activity-dependent axonal ATP dynamics in acute
optic nerve preparations. This novel approach expands our
previously described optic nerve imaging method (Trevisiol
et al., 2017), allowing more flexibility to express and study
dynamics of any biosensor of interest in optic nerve axons.
Using our protocol the many established metabolite sensors,
such as those for monitoring intracellular glucose (Takanaga
et al., 2008), lactate (San Martin et al., 2013), pyruvate
(San Martin et al., 2014a) or NADH (Hung et al., 2011;
Zhao et al., 2011, 2015), when packed into appropriate
AAV vectors, could be reliably expressed and studied in
optic nerves from wildtype or genetically modified mice at
different ages.
Long-term white matter integrity critically depends on
oligodendroglial support functions (Griffiths et al., 1998; Lappe-
Siefke et al., 2003; Snaidero et al., 2017) and recent studies have
highlighted that myelinated axons may well receive metabolic
support in the form of lactate from glycolytic oligodendrocytes
(Fünfschilling et al., 2012; Lee et al., 2012; Saab et al., 2016).
Using our versatile AAV-mediated approach to investigate
metabolite sensors dynamics in myelinated axons may help to
further resolve cellular and molecular mechanisms underlying
oligodendroglial support functions in regulating axonal energy
homeostasis. For example, axonal metabolite dynamics could
be studied in mouse mutants with oligodendrocyte- or myelin-
specific defects that develop axonal pathology (Griffiths et al.,
1998; Lappe-Siefke et al., 2003; Kassmann et al., 2007; Lee
et al., 2012; Saab et al., 2016) to better understand whether
and how axonal metabolite homeostasis may be perturbed
before the onset of axonal degeneration. Moreover, establishing
biosensor expression in oligodendrocytes, ideally with a similar
viral-mediated approach although technically more challenging,
would be a significant expansion of our current optic nerve
recording/sensor imaging method to further interrogate the
axon-glial unit.
In optic nerves action potential propagation is
well-maintained when exogenous lactate or pyruvate is supplied
as the main energy source (Brown et al., 2001). And during
periods of low glucose availability or aglycemia, lactate supply
from astrocytic glycogenolysis becomes critical in sustaining
optic nerve conduction (Wender et al., 2000; Brown et al.,
2004; Tekkök et al., 2005). Inhibiting mitochondrial respiration
with sodium azide in the presence of 10 mM glucose quickly
diminishes axonal ATP levels and completely blocks nerve
conduction (Figures 5, 6), suggesting that optic nerve axons are
primarily fueled by oxidative phosphorylation (Trevisiol et al.,
2017). On the other hand, axonal conduction in corpus callosum
slice preparations is not well-preserved when exogenous lactate
or pyruvate is supplied during glucose deprivation (Meyer et al.,
2018). Interestingly, in these aglycemic conditions callosal axons
are sufficiently energized to fire action potentials when glucose
is presented through the gap junction-coupled oligodendroglial
network, suggesting that glucose and/or endogenously generated
lactate is transferred to axonal compartments (Meyer et al.,
2018).
However, it remains uncertain how intracellular metabolites
such as glucose, lactate or pyruvate are distributed between
astrocytes, oligodendrocytes and the axonal compartment in
different white matter tracts. Do axons take up and metabolize
glial-derived lactate during physiological activity or only
during metabolic stress such as aglycemia or post-ischemia?
Do glial cells provide primarily lactate/pyruvate, or could
unphosphorylated glucose also be shuttled to fuel axonal energy
metabolism? How does glycolytic activity in glial cells or axonal
compartments increase during electrical activity? What are the
signaling mechanisms regulating activity-dependent axon-glia
metabolic coupling? In future studies, metabolite sensor imaging
in white matter tracts will help to resolve how different cellular
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compartments interact and exchange metabolites. Measuring
activity-dependent axonal metabolite dynamics in acute optic
nerve preparations provides a powerful tool to address some of
these challenging questions. This opens an exciting avenue for
future studies to interrogate molecular and cellular mechanisms
of white matter energy metabolism and axon-glial metabolic
coupling.
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